<DOC>
	<DOC>NCT01314365</DOC>
	<brief_summary>The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).</brief_summary>
	<brief_title>DYSPORTâ„¢ Clinical &amp; Health Economics Outcomes Registry in Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<criteria>A diagnosis of idiopathic CD as determined by the enrolling investigator If previously treated with a neurotoxin for CD, at least a 12week interval must have elapsed between the last injection of Botulinum toxin A (BoNTA) or Botulinum toxin B (BoNTB) and the first dose of Dysport injected in this study Patient is able to comply with the protocol (e.g., can visit the clinic as required and can complete questionnaires/telephone interviews) Provision of written informed consent prior to enrollment Contraindications to treatment with any BoNTA or BoNTB preparations Based on Investigator opinion, patients in whom previous BoNTA or BoNTB therapy has failed to produce a clinical response or produced an intolerable adverse reaction Anticipated concomitant treatment with BoNT for other than cervical dystonia Secondary cervical dystonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>